pharma
Enough talk: Action is required to achieve parity in biotech
August 6, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Takeda, Women in pharma, diversity, feature, pharma, women
Liz Lewis, Chief Counsel & Head of Patient Advocacy at Takeda Oncology tackles the crucial and topical issue of diversity …
Jazz Pharmaceuticals to expand Irish workforce across Dublin, Athlone sites
August 6, 2018Manufacturing and Production, Sales and Marketing Dublin, Ireland, jazz pharmaceuticals, pharma
Jazz Pharmaceuticals has announced its intention to expand its staff numbers at two of its bases in its home country …
England’s top GP resigns over imflammatory online comments
August 6, 2018Medical Communications, Research and Development, Sales and Marketing Dr Armind Madan, England, GP, pharma
England’s most senior General Practitioner and Director of Primary Care and Deputy Medical Director at NHS England has resigned over …
Novo Nordisk Pharmatech A/S enters a distribution agreement with Signet Chemical Corporation
August 3, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novo Nordisk, pharma, signet chemical corporation
Novo Nordisk Pharmatech A/S enters a distribution agreement with Signet Chemical Corporation Pvt. Ltd. for cGMP Quaternary Ammonium Compounds for …
Almirall picks up Allergan’s dermatology portfolio to for $650m
August 3, 2018Medical Communications, Sales and Marketing Allergan, Almirall, dermatology, pharma
Allergan has sealed a deal to sell its dermatology portfolio, comprising five brands, to Spanish pharmaceutical firm Almirall for $650 …
Epizyme shuts down failing lymphoma trial as FDA imposes clinical hold
August 3, 2018Medical Communications, Research and Development Epizyme, FDA, lymphoma, pharma, tazemetostat
Epizyme’s Q2 financial results have been derailed by the company’s decision to terminate further Phase 2 development of its lead …
Novartis hands over global rights for two oncology drugs to Shanghai’s Laekna
August 2, 2018Sales and Marketing Cancer, Laekna, Novartis, oncology, pharma
Novartis has revealed that it has jettisoned two of its clinical stage oncology products along with exclusive global development and …
Two injured in chemical incident at Sanofi lab in Ireland
August 2, 2018Manufacturing and Production Ireland, Sanofi, pharma
Two female employees have been injured in a chemical incident at a Sanofi lab at the company’s Waterford site in …
Otsuka scores EU schizophrenia approval, but acute myeloid leukaemia drug flops at Phase 3
August 1, 2018Research and Development, Sales and Marketing Astex, Otsuka, Rxulti, guadecitabine, pharma, schizophrenia
It’s bittersweet news for Otsuka as it emerges that the European Commission saw fit to approve its therapy Rxulti (brexpiprazole) …
Pfizer notches two EU approvals, including Herceptin biosimilar
August 1, 2018Research and Development, Sales and Marketing Cancer, EMA, EU, Genetech, Herceptin, Pfizer, Trazimera, Xeljanz, biosimilar, breast cancer, pharma
Pfizer is patting itself on the back after securing two new approvals in Europe within 24 hours: Xeljanz (tofacitinib citrate) …
Novartis migraine prevention drug scores EU approval
July 31, 2018Manufacturing and Production, Sales and Marketing Aimovig, Europe, Novartis, migraine, pharma
Novartis is celebrating the news that its calcitonin gene-related peptide receptor (CGRP-R) pathway therapy Aimovig (erenumab) has been approved by …
Progenics’ Azedra becomes first FDA-approved treatment for adrenal tumours
July 31, 2018Manufacturing and Production, Sales and Marketing Cancer, FDA, Progenics, adrenal cancer, pharma
The FDA has approved its first-ever drug for rare, unresectable tumours of the adrenal gland with its decision to authorise …
Wockhardt launches $40m manufacturing plant in Dubai
July 30, 2018Manufacturing and Production, Sales and Marketing Antibiotics, Dubai, India, Wockhardt, antibiotic resistance, pharma
Indian pharmaceutical firm Wockhardt has launched its first manufacturing facility in Dubai’s Jebel Ali Free Zone (Jafza). Costing $40 million, …
Gilead’s CEO and Chairman to both step down before year’s end
July 30, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Gilead, pharma
Gilead has announced that its President and Chief Executive Officer Dr John Milligan (pictured) will be stepping down by the …
Living with Behçet’s disease
July 30, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Behçet's disease, patient experience, pharma
Suzanne Morris speaks to Pharmafocus to discuss her life with Behçet’s disease, a rare condition characterised by the inflammation of …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
